Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company. September 28, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today. “Nutra Pharma Corporation learned today that the Securities and Exchange Commiss

Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing an update on the work of EuroAmerican IP, LLC to create awareness and sales into military and governmental buyers. September 25, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that their work with EuroAmerican IP, LLC has